Trial Profile
Phase II study of TAK-875 in subject with diabetes.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Fasiglifam (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Takeda
- 27 May 2016 New trial record